Kenneth Bate's Net Worth

$4.25 Million

Who is Kenneth Bate?

Kenneth Bate has an estimated net worth of $4.25 Million. This is based on reported shares across multiple companies, which include MADRIGAL PHARMACEUTICALS, INC., Coley Pharmaceutical Group, Inc., BIOMARIN PHARMACEUTICAL INC, Vanda Pharmaceuticals Inc., AVEO PHARMACEUTICALS, INC., GENOCEA BIOSCIENCES, INC., Astria Therapeutics, Inc., Epizyme, Inc., CUBIST PHARMACEUTICALS INC, NITROMED INC, and MILLENNIUM PHARMACEUTICALS INC.

SEC CIK

Kenneth Bate's CIK is 0001210238

Past Insider Trading and Trends

2013 was Kenneth Bate's most active year for acquiring shares with 10 total transactions. Kenneth Bate's most active month to acquire stocks was the month of May. 2023 was Kenneth Bate's most active year for disposing of shares, totalling 12 transactions. Kenneth Bate's most active month to dispose stocks was the month of December. 2010 saw Kenneth Bate paying a total of $681,000.00 for 65,857 shares, this is the most they've acquired in one year. In 2015 Kenneth Bate cashed out on 175,076 shares for a total of $980,730.00, their largest year based on trade value.